Antitumor activity and metal complexes of the first transition series. Trans-bis(salicylaldoximato)copper(II) and related copper(II) complexes, a novel group of potential antitumor agents-Reference-Cited by-同舟云学术

Antitumor activity and metal complexes of the first transition series. Trans-bis(salicylaldoximato)copper(II) and related copper(II) complexes, a novel group of potential antitumor agents

Published:1984-08 Issue:4 Volume:92 Page:241-251
ISSN:0020-1693
Container-title:Inorganica Chimica Acta
language:en
Short-container-title:Inorganica Chimica Acta

Author:

Lumme Paavo,Elo Hannu,Jänne Juhani

Publisher

Elsevier BV

Subject

Materials Chemistry,Inorganic Chemistry,Physical and Theoretical Chemistry

Reference31 articles.

1. Platinum Compounds: a New Class of Potent Antitumour Agents

2. Antileukemic platinum(II)–catecholamine complexes

3. Transition metal complexes in cancer chemotherapy

4. Preliminary studies on the inhibitory effect of novel Pd(II) complexes of vitamin B6 on cell divisions

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Structural Investigation of a Series of Prodigiosin and 1,10-Phenanthroline Derivatives as Novel and Highly Potent Anticancer Therapeutic Drugs or Active Pharmaceutical Ingredients;Karadeniz Fen Bilimleri Dergisi;2024-03-15

2. Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (Ps) derivatives and their Copper(I) complexes against mTOR and HDAC enzymes as highly potent and effective new anticancer therapeutic drugs;Frontiers in Pharmacology;2022-10-04

3. Hydrogen Storage Capacity and Thermodynamic Calculations of Mercury(II) and Palladium(II) Syn‐2‐Pyridine Aldoxime Complexes;Macromolecular Symposia;2022-02

4. Cadmium(II) and copper(II) complexes containing benzoate derivatives and 2-aminopyrimidine ligands: Synthesis, crystal structures and antibacterial activity;Journal of Physics: Conference Series;2022-01-01

5. Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment;European Journal of Medicinal Chemistry;2021-02